RxDoctor Payments Data

George Demellis

Family · Holiday, FLNPI 1497260947

Payments from drug & device makers

$8,850in general payments, 2019–2025

Across 238 payments — averaging $37.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$3K
  • Novo Nordisk$1K
  • Biohaven Pharmaceuticals, Inc.$941
  • AbbVie$584
  • Bayer$509
  • Lilly USA, LLC$408
  • plus $2K from 25 others

What the payments were for

  • Consulting fees$1,80020%
  • Speaking & faculty fees$2,13524%
  • Travel & lodging$350%
  • Food & beverage$4,88055%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,850 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$67,355
MounjaroTirzepatide65$67,014
JardianceEmpagliflozin34$44,697
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,385
Rosuvastatin Calcium43$635
Ezetimibe24$307
Levothyroxine Sodium26$225
Doxycycline Hyclate14$190
Losartan Potassium13$123
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$117
Lisinopril20$108
Temazepam16$93
Pioglitazone Hcl14$78
Prednisone18$50

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,108$67,35553 claims
Lilly USA, LLCMounjaro$408$67,01465 claims
Boehringer IngelheimJardiance$48$44,69734 claims
GSKTrelegy Ellipta$159$8,38512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.

Other family in Holiday

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →